PHARMAZEUTISCHE FORMULIERUNGEN

Patent europeic · EP4527467 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4527467
Numer da la dumonda
EP24216441
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
29-06-2016
Publitgà
26-03-2025
Concedì
18-03-2026
La protecziun finescha il pli tard
28-06-2036
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
A61K 9/20 (2006.01)
A61K 9/24 (2006.01)
A61K 31/513 (2006.01)
A61K 31/675 (2006.01)
A61K 9/00 (2006.01)
A61K 9/28 (2006.01)
A61P 43/00 (2006.01)
A61P 31/18 (2006.01)
Prioritad
US 201562187113 P 30.06.2015
US 201662298373 P 22.02.2016
US 201662301429 P 29.02.2016
US 201662317286 P 01.04.2016
Derivà da
EP23162978
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 15-04-2026

    Represchentant inscrit

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 15.04.2026

  3. 18-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 18.03.2026

Partidas

Possessur

Gilead Sciences, Inc.

333 Lakeside Drive, Foster City, CA 94404, US

Represchentant

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

Inventur

KOZIARA, Joanna, M.

Foster City, 94404, US

MCCALLISTER, Scott

Foster City, 94404, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.